BetterLife Pharma annual return on equity
2010
2019
2020
BetterLife Pharma Return on Equity (ROE) Growth & History (BETRF)
BetterLife Pharma's return on equity was −635.36% for fiscal 2020.
View full BetterLife Pharma company overviewBetterLife Pharma annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-01-31 | −635.36% | −105.73 pp |
| 2019 | 2019-01-31 | −529.63% | — |
| 2010 | 2010-01-31 | −708.88% | — |
BetterLife Pharma quarterly return on equity
Q2.16
Q3.16
Q1.20
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2020 | 2019-04-30 | −54.50% | — |
| Q3 2016 | 2015-10-31 | −8.45% | — |
| Q2 2016 | 2015-07-31 | −4,892.37% | — |
BetterLife Pharma return on equity trends
Between the periods ended 2010-01-31 and 2020-01-31, BetterLife Pharma's return on equity increased from −708.88% to −635.36%, a change of +73.52 percentage points. The latest reported quarter, Q1 2020, shows −54.50%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BetterLife Pharma source filings ↗